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Abstract
Background: Muscular weakness and severe vitamin D deficiency is prevalent in Somali (veiled) pregnant women,
Sweden. The study aims here were to explore adherence to prescribed supplemental vitamin D in new mothers
with vitamin D deficiency and its effects on grip strength and upper leg performance in Somali (target group TG)
and Swedish women (reference group RG) from spring through winter.
Methods: A before- and after study was designed. A cross-sectional sample of women in antenatal care with
serum 25-OHD ≤50 nmol/L were prescribed one or two tablets daily (800 or 1600 IU vitamin D3 with calcium) for
10 months. Reminders were made by Somali nurses (TG) or Swedish doctors (RG). Baseline and 10 month
measurements of plasma nmol/L 25-OHD, maximal grip strength held for 10 s (Newton, N) and ability to squat
(yes;no) were done. Total tablet intake (n) was calculated. Outcome variables were changes from baseline in grip
strength and ability to squat. Predicting variables for change in grip strength and ability to squat were calculated
using linear and binary regression in final models. Undetectable 25-OHD values (<10 nmol/L) were replaced with ‘9’
in statistic calculations.
Results: Seventy-one women (46 TG, 1/3 with undetectable baseline 25-OHD; 25 RG) participated. At the 10-month
follow up, 17% TG and 8% RG women reported having refrained from supplement. Mean 25-OHD increased 16 to
49 nmol/L (TG) and 39 nmol/L to 67 nmol/L (RG), (both p < 0.001). Grip strength had improved from 153 to 188 N
(TG) (p < 0.001) and from 257 to 297 N (RG) (p = 0.003) and inability to squat had decreased in TG (35 to 9, p < 0.
001). Intake of number of tablets predicted increased grip strength (B 0.067, 95%CI 0.008–0.127, p = 0.027). One
tablet daily (>300 in total) predicted improved ability to squat (OR 16; 95% CI 1.8–144.6).
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Conclusions: Adherence to supplemental vitamin D and calcium should be encouraged as an even moderate
intake was associated to improved grip strength and upper leg performance, which was particularly useful for the
women with severe 25-OHD deficiency and poor physical performance at baseline.
Trial registration: ClinicalTrials.gov Identifier: NCT02922803. Date of registration: September 28, 2016.
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Background
Muscular strength is crucial for delivering and caring an
infant. However, some women have weak muscles and
what do we do for them? An increased muscle power,
often measured as grip strength and ability to perform
muscular activities, should be an important issue for
antenatal care providers in order to secure good and safe
childbirth and care for the newborn.
Our former study, performed in springtime, showed a
very poor grip- and leg strength and severe vitamin D
deficiency (<25 nmol/L) in 90% of pregnant or newly
pregnant Somali women living in Sweden. Similar find-
ings were found in 10% of the native pregnant women.
Grip strength was positively associated with 25-OHD
levels also when adjusted for country of birth, age and
height [1].
Muscles respond to mechanical loading and metabolic
distress [2–4], and vitamin D plays a crucial role in
muscle function [5], calcium absorption and in
maintaining homeostasis [6]. To note, impaired muscle
function may be present before the biochemical signs of
bone disease appears [7, 8]. Few or no studies have
examined adherence to supplemental vitamin D medica-
tion in long-term and its effect on muscle strength in
pregnant women focusing on those wearing veiled
clothing [9].
The study aims here were to explore adherence to
prescribed supplemental vitamin D in pregnant and
recently pregnant women with vitamin D deficiency and
its effects on grip strength and upper leg performance in
Somali (target group; TG) and Swedish women (refer-
ence group; RG) from spring through winter.
Methods
Design
A pre- and post-treatment study design was used. The
study was initiated in late spring (baseline) to take advan-
tage of the low UV B radiation conditions during winter.
We chose a retrospective inclusion design that enabled us
to complete blood sampling and physical tests within a
limited period of time. Thus, the baseline sample included
women in all trimesters as well as recent mothers. A 4-
month check-up was performed during autumn (Time I).
The primary outcome data were collected at the
10-month follow-up, after winter (Time II).
Setting
The study took place in a primary care antenatal clinic
in central Sweden (latitude, 60th parallel north).
Recruitment
Study participants were recruited from women regis-
tered at the antenatal clinic during 2010 [1]. We
excluded women <18 years of age, women born in coun-
tries other than Somalia and Sweden and women with
severe disorders such as severe metabolic, medical or
mental disease (ex. severe diabetes or psychosis).
Information material was translated into Somali and
read aloud as needed. Veiled clothing was defined as
clothing covering the woman’s arms, legs and head. A
total of 217 women were randomly selected based on
primi- or multiparity and recruited via letter and tele-
phone. In total, 140 women agreed to participate in the
study and had initial blood tests. One week later, 123
women attended the baseline physician consultation for
physical performance tests, supplemental vitamin D pre-
scriptions when needed and brief lifestyle information.
Study sample
Of the 123 women who participated at baseline, 89 had
25-OHD ≤50 nmol/L. Included in analyses are 46 Somali
women in the target group (TG) and 25 Swedish women
in the reference group (RG) who also attended the
10-month follow-up measurements (Time II). Liver
enzyme levels were normal at baseline.
Intervention
A vitamin D3 supplement containing calcium (800 IU =
20 μg vitamin D3 and 500 mg calcium carbonate) was
prescribed. The over-the-counter price was 309 SEK per
180 tablets (approximately 44 USD) and the women paid
these themselves. Two tablets daily was prescribed for the
women with 25-OHD <25 nmol/L and once daily for
those with 25–50 nmol/L of 25-OHD. These doses
followed the recommendations for pregnant women [10].
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Data collection
Professional interpreters supported data collection from
Somali women. Anthropometric measurements were
collected. Data on breastfeeding and gestational age were
noted and Body Mass Index (BMI) was calculated. Phys-
ical activity was self-reported on a 3-point scale: seldom,
sometimes or often (≥3 times weekly). Questions about
medication and side effects were asked during the
follow-up meetings. The research physicians were
blinded to the blood test and previous test results during
the consultations.
Blood samples
Venous blood samples were drawn and centrifuged.
Serum vitamin D (25-OHD) was measured using the
Liaison 25 OH Vitamin D total assay (DiaSorin,
Stillwater, USA) at Akademiska Laboratoriet, Uppsala,
Sweden. The other assays (s-ALAT, s-ALP, fP-PTH and
serum albumin corrected Ca) were measured using
Abbott Architect ci8200 (Abbott Laboratories, Illinois,
USA) at the Department of Clinical Chemistry, Falun
Hospital, Sweden. Alkaline phosphates (s-ALP), fasting
parathyroid hormone (fP-PTH) and free serum calcium
were analysed to monitor metabolic skeletal activity. The
same laboratories and assays were used on all test occa-
sions. Serum 25-OHD was used as the indicator of
vitamin D status and fP-PTH and s-ALP were indicators
of bone turnover at baseline and 4 months.
Haemoglobin and glucose were measured in the base-
line blood samples to screen for non-vitamin-D-related
reasons for fatigue and muscular weakness.
Grip strength and upper leg performance
Physical performance tests in the hands and upper legs
were chosen because they reflect everyday uses. Test
outcomes were rated by the same researcher physicians
on all occasions.
Grip strength
Maximal grip strength held for 10 s (Newton, N) for
testing endurance was measured three times in each
hand using a hand dynamometer at each assessment
(GRIPPIT AB Detektor, Gothenburg, Sweden) [11]. The
mean value was used in the analyses (M-max grip). Also
peak grip strength was measured at all times.
Upper leg performance
Four upper leg tests were rated by the research physi-
cians on a 3-point ordinal scale: able (0), with help (1) or
unable (2), and later categorized as: able (0) or unable (1
and 2). The tests included:
a. Squatting. The person squatted and rose once.
b. Standing on one leg for 30 s.
c. Hip lifting (Trendelenburg’s test). The person held
one hand high up on a wall and lifted the opposite
leg for 30 s.
d. Rising from a chair five times in a row while folding
arms across chest. This test was later omitted from
analyses because all participants accomplished it.
Medication
Daily consumption of prescribed tablets and compliance
to the medication dosage were asked for at follow-up
appointments and total number of tablets consumed for
10 months was estimated based on this information.
Ethical approval
Written consent was given by participants. The study
was approved by the regional ethics committee in
Uppsala, Sweden (D 2010/140 and 2010/140/1).
Power calculation
Statistical power was calculated based on an upward
clinically relevant mean difference in grip power of 50 N
(Std 40). On this basis, at least seven participants were
needed in the TG and 17 in the RG (mean change 40,
Std 50) for a two-sided t test to reach 90% power with
an alpha error of 5%.
Statistical analyses
The study sample was divided into two groups, TG and
RG. Levels of 25-OHD were examined and categorized
according to standards as: un-measurable <10 nmol/L
(coded as 9 in statistical calculations), 10–24 nmol/L or
25–50 nmol/L. Mean values (intervals) and standard
deviations (Std) were calculated. We used Chi square
statistics for nominal data and Mann–Whitney U test to
test for significant differences in median and mean
values between groups for both non-normal and
normally distributed variables. Non-parametric tests for
significant differences between pre–post values were
conducted using McNemar’s test (for dichotomous data)
or Wilcoxon signed-ranks test (for ordinal or interval
data). Uni-variate associations were explored using
Spearman rho to assess correlations between the num-
ber of tablets taken and the difference scores between
Baseline and Time II on 25-OHD, M-max grip and
upper leg performance.
We used multiple linear regression with stepwise
exclusion to estimate the independent variables that was
best associated with the change of grip strength from
baseline to Time II.
We used binary regression to calculate odds ratios
(OR) with 95% confidence intervals (95% CI) as
predicting positive changes in upper leg physical
performance in the TG.
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Independent variables age, total tablets taken, height,
increased physical activity and 25-OHD increase were
categorized as below and above their mean values.
Data were analysed using SPSS, version 20.
Results
Despite reminders, 5 of the 51 (10%) in the TG and 15
of 40 (38%) in the RG did not participate further (drop-
outs). They did not differ significantly in any aspects
from those who continued. The five TG women had not
given any motives but some of the RG women said they
felt fine and therefore did not want to participate
further.
In addition, the gelatine component of the tablets had
worried a few TG women but they were satisfied when
told that it was from a bovine source. A few women
reported initial gastric irritation.
Table 1 shows that the 25 RG women were older (p <
0.05), taller (mean height 167 cm vs. 161 cm, p < 0.001),
more educated (mean 14 years vs. 3 years, p < 0.001) and
had lower parity (1 vs. 3, p < 0.001) than the TG women.
All, except two TG women, had very low or un-
measurable (37%) 25-OHD levels with an estimated
mean of 16 (median 12 nmol, not in table), compared
with 39 nmol/L in the RG, and with fP-PTH and s-ALP
levels above the reference limits.
Seventeen (37.0%) women in TG were pregnant (mean
months 6.2, Std 1.3) compared to 15 (60.0%) in RG (mean
months 6.0, Std 1.7). In TG 28 (60.9%) women were
breastfeeding compared to 9 (36.0%) in RG.
Check-up Time I at 4 months (data not shown in tables)
Objectively, the 38 TG women had significantly
improved their peak grip strength from a mean of 199 N
(Std 59) to 214 N (Std 49) (p = 0.037, Wilcoxon signed-
ranks test) and were more able to squat effortlessly (p <
0.001). At this time point, no TG woman had an
immeasurable 25-OHD level; their group mean was 47
(Std 28) nmol/L vs. the initial estimated mean of 15.8
(Std 9.7) nmol/L (p < 0.001). Furthermore, their mean
fP-PTH levels decreased to 8.3 (Std 3.1) from 13.0 (11.5)
pmol/L at baseline (p < 0.001). The RG women also had
increased 25-OHD to 64 nmol/L (Std 26) vs. 39 (Std 10)
at baseline (p < 0.001).
Check-up Time II at 10 months
Eight (17%) in the TG vs. two (8%) of the RG reported
having not taken any supplement. Thus, there was a
large variation in the calculated mean total intake of
tablets at Time II : n = 322 (Std 239) in the TG and
n = 211 (Std 136) in the RG.
Mean 25-OHD levels were stable compared with Time
I (47 to 49 nmol/L TG; 64 to 67 nmol/L RG).
The increased levels of 25-OHD correlated with total
tablet intake in the TG (rho. 0.53, p < 0.001).
Many women reported increased physical activity
compared to baseline; 21/46 in TG (ns) and by 14/25 in
RG (p < 0.001).
Table 2 shows baseline and Time II levels of 25-OHD,
grip strength and the number of women unable to per-
form the upper leg performance tests at baseline and
Time II. At time II, the TG women had significantly
higher 25-OHD and grip strength and the number of
women unable to keep their hip up and to squat
decreased significantly. More than half (26 of 46; 57%)
of the TG women improved their squatting ability. None
improved on the one-leg standing task. Likewise, the RG
women had significantly higher 25-OHD values at Time
II, as well as a stronger grip strength (mean 257 N vs.
297 N, p = 0.003). This concerned even the women in
the higher strata.
Table 3 shows before and after values for strength and
25-OHD in 25-OHD categories of compliers (adhered to
medical advice) and non-compliers after 10 months of
treatment. In 25-OHD category 10–24 nmol/L, TG
women who took medication (compliers) increased their
grip strength with 28% (162 N–208 N, p < 0.001) and
25% (118 N–148 N, p = 0.039) in category <10 nmol/L.
Two thirds (64%) for the groups of TG women with <10
or 10–24 nmol/L who adhered to medical advice (com-
pliers) increased their leg strength significantly.
Figure 1 illustrates a scatterplot displaying the associ-
ation between total tablet intake and M-max grip
increase (rho 0.317, p = 0.032).
Table 1 Baseline characteristics for entire sample and participants
in the target and reference groups. Values are means with
standard deviation (Std), number (n) and frequencies (%)
Target group Reference group
All Participants All Participants
Number, n (%) 51 46 (90.2) 40 25 (62.5)
Age, years 28.3 (6.4) 28.0 (6.5) 30.4 (5.4) 30.6 (5.7)
Parity, n (%) 3.4 (2.7) 3.1 (2.5) 1.3 (1.1) 1.4 (1.1)
Education, years 3.4 (3.4) 3.5 (3.5) 13.9 (2.5) 14.3 (2.2)
Height, cm 161.5 (5.2) 161.4 (5.1) 167.0 (6.3) 167.2 (6.1)
25-OHD nmol/L 15.4 (7.8)a 15.8 (9.7)a 37.8 (9.5) 38.8 (10.3)
s-Ca, mmol/L 2.27 (0.12) 2.27 (0.12) 2.31 (0.07) 2.31 (0.06)
fP-PTH pmol/L 12.7 (11.0) 13.0 (11.5) 4.71 (2.49) 4.87 (2.90)
s-ALP, ukat/L 2.00 (1.40) 2.02 (1.45) 1.58 (0.77) 1.56 (0.76)
Reference ranges: fP-PTH, 1.1–6.9 pmol/L; s-albumin corrected calcium,
2.15–2.50 mmol/L; s-ALP, 0.60–1.80 ukat/L
a25-OHD values <10 nmol/L (unmeasurable) replaced with 9 for 17 women
(34%) in the entire sample and n = 17 (37%) among target group participants
Note: NS. drop-outs (n = 5 TG; n = 15 RG) vs. participants (Mann–Whitney
U test)
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Table 2 Mean (Std) values for the target and reference groups at baseline (time 0) and after 10-months (time II) of 25-OHD nmol/l
and grip strength; number and frequencies of those unable to perform the upper leg tests
Target group Reference group
N = 46 N = 25
Time 0 Time II p Time 0 Time II p
25-OHD mean (Std) 15.8 (9.7)a 49.2 (35.4) .001 38.8 (10.3) 67.5 (26.7) .001
Grip strength, N (mean, Std) 153 (55) 188 (57) .001 257 (68) 297 (58) .003
Unable to squat, n (%) 35 (76.1) 9 (19.6) <.001 0 (0) 1 (4.0%) 1.000
Unable to stand on one leg, n (%) 11 (23.9) 11 (23.9) 1.000 1 (4.0) 0 (0) 1.000
Unable to keep hip up, n (%) 10 (21.7) 1 (2.2) .004 1 (4.0) 0 (0) 1.000
a Mean 25-OHD estimated at 9 for n = 17 women with unmeasurable 25-OHD (<10 nmol/L) at Time 0. Significant differences before and after were calculated by
Wilcoxon signed-ranks test for interval data and McNemar’s test for dichotomous data
Table 3 Before and after values of 25-OHD and physical tests at baseline and 10 months (Time II) by target and reference groups
(participants) and categories of 25-OHD concentrations (nmol/L) groups based on 25-OHD levels at baseline and compliers or
non-compliers of supplement intake. Statistical significans with Wilcoxon
Target group Reference group
N 46 25
Compliers Non-compliers Compliers
n (%) 38 (82.6%) 8 (17.4%) 23 (92%)
25(OH)D categorya <10 10–24 25–50 <10 10–24 10–24 25–50
n 13 21 4 4 4 5 18
25(OH)D, mean (Std)
Baseline 9.0 (0.0) 16.1 (5.0) 39.0 (15.1) 9.0 (0.0) 19.8 (3.1) 22.5 (1.6) 42.0 (6.7)
10 m 50.5 (36.1) 57.9 (39.0) 60.3 (8.0) 15.0 (4.1) 22.6 (10.9) 66.3 (29.0) 66.6 (28.2)
p 0.001 <0.001 0.068 0.102 0.715 0.043 0.001
Physical performance
Grip (N), mean (Std)
Baseline 118 (64) 162 (36) 193 (103) 166 (37) 171 (23) 242 (51) 262 (76)
10 m 148 (65) 208 (46) 219 (54) 168 (37) 201 (43) 267 (34) 310 (59)
p 0.039 <0.001 0.465 0.593 0.144 0.080 0.010
Inability to: Squat, n(%)
Baseline 11 (84.6) 13 (61.9) 3 (75.0) 4 (100) 4 (100) 0 (0.0) 0 (0.0)
10 m 0 (0.0) 4 (19.0) 1 (25.0) 2 (50.0) 2 (50.0) 1 (20.0) 0 (0.0)
p 0.001 0.012 0.500 0.500 0.500 1.000
Stand on one leg, n (%)
Baseline 3 (23.1) 5 (23.8) 0 (0.0) 2 (66.7) 1 (25.0) 0 (0.0) 1 (5.6)
10 m 3 (23.1) 3 (14.3) 2 (50.0) 2 (66.7) 0 (0.0) 0 (0.0) 0 (0.0)
p 1.000 0.688 0.500 1.000 1.000 1.000
Keep hip up, n (%)
Base line 4 (30.8) 4 (19.0) 0 (0.0) 1 (25.0) 1 (25.0) 0 (0.0) 1 (5.6)
10 m 0 (0.0) 0 (0.0) 0 (0.0) 1 (25.0) 0 (0.0) 0 (0.0) 0 (0.0)
p 0.125 0.125 1.000 1.000 1.000
Note: aCategorized 25-OHD values due to unmeasurable values and treatment strategies at baseline
Bold data are significant
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Table 4 shows the final effect model for grip strength
change. Total tablet intake was positively associated with
improved grip strength (p = 0.027), adjusted for height
(p = 0.036).
Table 5 shows the OR for improved squatting ability
in the target group with 95% CI in a final model. The
OR for intake of one tablet at least once daily for
10 months (300 tablets or more) showed an OR of 16.0
(95%CI 1.8–144.6).
Discussion
To sum up, the adherence to the prescribed supplement
regiment was good in this target group of women, with
critically low 25-OHD levels and very poor muscular per-
formance at baseline. Taken all participants together, the
improved grip strength was significantly associated to the
number of tablets taken and this was also the case with
improved upper leg performance in the target group.
What is new?
To our knowledge, there are no previously published
real life studies of the usefulness of prescribing supple-
mental vitamin D for improving grip strength and upper
leg performance to low-educated new immigrant and
veiled non-Western pregnant (and recently pregnant)
women with severe vitamin D deficiency. In addition,
there are few reports of supplement efficacy to younger
women with less severe vitamin D deficiency to improve
their grip strength.
Discussion of results
This was a real life study in a multicultural primary care
made in cooperation with the antenatal care. We targeted
women at special risk for complications due to severe vita-
min D deficiency. Path ological bone turn-over at baseline
was significantly reduced already after a few months.
Like most Western countries, Sweden as a country has
an influx of refugees from the global conflict regions
thus changing the ill-health patterns in the population
and brings up a need for new clinical practices [12, 13].
Non-adherence to medication and advice can be due to
lack of cultural competence from a care-giver perspective
leading to that clinical needs are missed [14] such as the


















Fig. 1 Scatter plot for total tablet intake and change in grip strength (M-max grip, measured in Newton [N]) from baseline to Time II (10-month
follow-up) for the target group (TG) women, n = 46. Spearman’s rho 0.32, p = 0.032. M-max grip was mean maximal grip held for 10 s
Table 4 Final model using multiple linear regression for
improved Mean maximal grip strength held for 10 s at 10-month
follow-up (time II). Unstandardized B with 95% confidence
intervals (95% CI) (N = 71)
B p-value 95% CI for B
Lower Upper
Total tablet intake .067 0.027 .008 .127
Change in 25-OHD -.338 0.092 –.733 .056
Height .060 0.036 .157 3.966
Adjusted R2 0.100. Variables entered in the first model: age, height, country of
birth, total tablet intake, 25(OH)D change and physical activity change
Table 5 Odds ratios with 95% confidence intervals (95% CI) for
improving squatting ability in target group. Final full model
p OR 95% CI
Lower Upper
Total tablet intake > 300 .014 16.0 1.8 144.6
Variables entered at step one: age > 28 years, height > 161 cm, decreased BMI,
increased 25-OHD > 33 nmol/L, tablet intake > 300, increased physical activity
Nagelkerke R square: Step 1; 0.359 Final step; 0.315
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deficient levels of vitamin D (25-OHD) in pregnant non-
Western women living in Europe [15–17], in adolescent
girls in England [18], and in post-partum mothers [15].
Lack of vitamin D also occurs in high frequency in native
populations of women in Beijing [19] and Denmark [20]
while Swedish women in general practice seldom have
levels below 25 nmol/L [21]. Notably, no clinical data were
provided in any of the above mentioned studies.
A standard estimate of appropriate serum 25-OHD is
50 nmol/L [6, 8, 22, 23]. Our TG women had much
lower values and even immeasurable 25-OHD (i.e.,
<10 nmol/L) levels and also very weak hands and legs.
With supplementation, their 25-OHD levels increased to
50 nmol/L 25-OHD which apparently had contributed
to improve their grip strength 25% on the average. Yet,
their mean grip strength value was only 188 N, which
still was 80 N below the “normal” mean value for healthy
Swedish women (268 N for 20–29 years) [11]. Also, a
quarter of the TG women could not stand on one leg at
any time. This finding is unclear and worthy of further
investigation, as are the other possible explanations for
weak handiness. One fifth of the TG women had a posi-
tive Trendelenburg’s test at baseline, compared with only
a few at Time II not possible to relate directly to tablet
intake probably due to small number of persons.
Long recognised as important for bone health, vitamin
D has attracted interest also for its possible non-skeletal
benefits. Whether supplemental vitamin D lowers and at
what dose is required to reduce health hazards is uncer-
tain [24]. More is not necessary better, as shown here
when a moderate dose of 800 or 1600 IU vitamin D3
was beneficial also for women with very poor status. In a
multicultural clinical trial like this it is impossible to
correct for all confounders. Here we previously have
accounted for many likely confounders but only physical
activity was found relevant.
Grip strength is a measure of upper extremity function
commonly used as a general indicator of frailty among
older adults. Here, improved grip strength and ability to
squat correlated to the number of tablets consumed
rather than the laboratory levels of 25-OHD, and so
likely indicating the importance of calcium content
when it comes to improving skeletal muscle function.
The cut-off points for S-25-OHD were from the
laboratory [10]. Our laboratory consistently returned
values 10–20% lower than the precise LC-MS reference
methods used at other laboratories [25].
Some authors have suggested 75 nmol/L of 25-OHD
as optimal for soft tissue health [10, 22, 26, 27]. Our RG
women with better baseline values (25–50 nmol/L 25-
OHD) also increased their 25-OHD levels significantly
and increased their grip strength from subnormal levels
(mean 257 N) to the normal mean value for 30–39-year-
old Swedish women [11].
Clinically, both appearance and gait among the TG
women had improved by Time I. Here, we assessed
physical performance as separate tests and not a sum-
mary score that sometimes is used to illustrate a broad
measure of physical performance [27]. We considered
separate measures of performance easier to manage in a
multicultural clinical practice.
Gestational age and breastfeeding indicating also
oestrogen status may theoretically influence performance
of physical tests but no such relation was found here,
nor in our previous study [1].
The association between serum vitamin D, supplemen-
tal vitamin D and physical performance is still poorly
understood. Our low correlation values between
25-OHD and improved grip strength could be partly
explained by the conservative replacing method for
immeasurable 25-OHD values and/or a total body
calcium deficiency. Participants also reported an increase
in their physical activity but this could not be used to
explain their improved test results.
Strengths and limitations
This study is by us considered to have a good ecological
validity. A problem we faced was the difficulty of enrol-
ling pregnant and recent mothers. Language and cultural
differences were additional barriers, but in spite of this
most of the TG women enrolled when the Somali assist-
ant nurses contacted them.
To note, the dropout rate was higher among the more
affluent reference women than among the marginalized
target group women. This may have distorted some of
the results, which must in any case be interpreted with
caution due to the small sample size from a single site.
Our results cannot be generalized but should be
possible to transfer to similar patient settings as here,
and they might also be relevant for individuals with low
UV exposure for prolonged periods.
Regrettably, a randomized controlled intervention
study was not possible to perform due to ethical
concerns. Instead, we performed this in situ study in a
single setting with a limited number of participants at
risk.
Comparison with other studies
Hypovitaminosis D can jeopardize development of the
foetus and cause neonate hypocalcaemia, which
motivated us to focus on pregnant women in our study
[10]. Many studies conclude that vitamin D deficiency is
common in middle Eastern female immigrants but that
their response to prescribed vitamin D dosages is often
inadequate [28].
This real life study included persons with minimal
UV-exposure during an extended time. Here, the esti-
mated level increase of 25-OHD was 31 nmol/L per
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800 IU (20 ug) vitamin D3 plus 500 mg calcium in the
TG and even 41 nmol/L in RG compared to a lower
increase of 25 nmol/L at intake of 1000 IU according to
previous literature [29]. The comparatively higher result
in RG could be due to more UV-exposure but this needs
further investigation. Our results may provide a formula
for calculating the amount of supplemental intake in
pregnancy during long-term to increase 25-OHD levels
to normal in similar groups of persons with low UV-
exposure.
Cutaneous synthesis of vitamin D3 decreases with age
inducing interest in the vitamin D status and lower
extremity functioning of older adults [8] but the rela-
tionship between muscle strength and supplemental
vitamin D has been discrepant with regard to muscle
strength and function [30].
Cross-sectional studies have shown a positive relation-
ship between muscle strength, performance and
25-OHD levels among postmenopausal women having
levels below 60 nmol/L and in hip-fracture patients
[31, 32]. In women 19–29 years with <50 nmol/L 25-OHD,
more physical activity was associated with both good grip
strength and higher serum 25-OHD [22].
Intervention studies have provided diverging results
depending on the study population and intervention
methods. On the positive side are studies of older adults
[8] and athletes with sub-optimal 25-OHD [22] in whom
supplemental vitamin D with calcium improved muscle
strength and athletic performance. An important point
here is that a combination of calcium and vitamin D was
found to be superior for improving muscle function
compared with calcium alone [33]. In a young adult
sample, Danish investigators found improved quadriceps
muscle power after vitamin D treatment in veiled Arabic
adult women [7]. On contrary, a Norwegian study of
non-Western adults, many of whom were from Somalia,
found that men and women with on average 25-OHD of
27 nmol/L did not benefit from 4 months of supplemen-
tal vitamin D, notably without calcium, as measured by
their power to jump, grip, or rise from a chair [34]. Fur-
thermore, a study of young women found no relation-
ship between increased 25-OHD and improved muscle
strength after having received vitamin D and calcium
[35]. However, small beneficial effects of supplemental
vitamin D on balance, gait or sit-to-stand performance
were found in community-dwelling older women [36].
Adherence studies of supplemental vitamin D intake
are few.
Clinical significance
In clinical practice, signs such as a weak handgrip, the
inability to squat or a waddling gait (also called Trende-
lenburg gait) indicate a severe vitamin D deficiency in
high-risk groups.
Giving supplements containing vitamin D and calcium
may help improve function and seem to be well
accepted, but support from native-speaking assistants
might be needed to improve adherence. Repeated
measurements of 25-OHD appear to be of little use and
might be replaced by tablet intake estimation and simple
physical performance tests.
Future studies
Our findings warrant further investigation, including
studies focusing on methods to improve adherence to
supplemental prescriptions where also costs of supple-
ments, attitudes and behaviour-related socio-cultural
factors should be explored by e.g., using qualitative
research methods. Future studies could also focus on
delivery outcome, efficacy in daily infant care, balance
and osteomalacia.
Conclusions
Adherence to supplemental vitamin D and calcium
should be encouraged as an even moderate intake was
associated to improved grip strength and upper leg
performance, which was particularly useful for the
women with critically 25-OHD deficiency and poor
physical performance at baseline.
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